
Dr. Vinod Raina is a renowned Medical Oncologist serving as Chairman of Oncosciences at Fortis Healthcare, with professional associations at Fortis Memorial Research Institute, Gurugram, and Fortis Cancer Institute, Defence Colony, New Delhi. With more than 40 years of professional experience, he specialises in the diagnosis and treatment of complex cancers and advanced medical oncology care.
He completed his MBBS from Government Medical College, Srinagar, followed by an MD in General Medicine from the All India Institute of Medical Sciences (AIIMS), New Delhi. He also holds MRCP from the United Kingdom, FRCP from the Royal College of Physicians and FAMS, reflecting his extensive postgraduate training and clinical experience.
His clinical expertise includes medical oncology, breast cancer, lung cancer, gastrointestinal and genitourinary malignancies, gynaecological cancers, lymphoma and multiple myeloma. He also has experience in bone marrow transplantation and the management of complex malignancies requiring multidisciplinary treatment approaches.
Before joining Fortis, Dr. Raina served as Professor and Head of Medical Oncology at AIIMS, New Delhi, where he spent more than two decades. He has contributed extensively to clinical research, cancer treatment programmes and medical education and is recognised for his work in advancing medical oncology in India.
Decades of expertise, proven results, and compassionate care — here is why patients from 50+ countries trust Dr. Vinod Raina for Hematology & BMT treatment in India.
Over 20 years of dedicated clinical experience with 5,000+ procedures. One of the most trusted names in Hematology & BMT in India.
Dr. Vinod Raina regularly treats patients from Africa, the Middle East, Central Asia, and Europe. Dedicated international patient support team available 24/7.
Practices at an internationally accredited hospital, ensuring patient safety standards that match the best hospitals in the USA and Europe.
World-class treatment at a fraction of USA, UK, or Australian prices. Transparent cost estimates provided before you travel.
Dr. Vinod Raina holds postgraduate qualifications from premier Indian institutions and has advanced fellowship training in Hematology & BMT.
Every case is personally reviewed. Treatment plans are tailored, transparent, and discussed in detail before you make any decisions or travel arrangements.
AML, CML, CLL, ALL, Hodgkin & Non-Hodgkin Lymphoma, Multiple Myeloma — treated with chemotherapy, targeted therapy & BMT.
Autologous, allogeneic, and haplo-identical BMT for leukemia, lymphoma, aplastic anemia, and inherited blood disorders.
Cutting-edge immunotherapy using genetically modified T-cells for blood cancers that have relapsed after standard treatments.
Curative BMT for thalassemia major and sickle cell anemia in children and adults. Low-cost programs available across India.
Both immunosuppressive therapy and stem cell transplantation for severe and very severe aplastic anemia, including pediatric cases.
HSCT (Hematopoietic Stem Cell Transplant) for aggressive Multiple Sclerosis — a disease-modifying treatment available in India.
Expert care for childhood leukemia, thalassemia, ITP, and inherited bone marrow failure syndromes.
Diagnosis and treatment of bone marrow failure and pre-leukemia syndromes with modern protocols.
Comprehensive management of hemophilia A & B, Von Willebrand disease, platelet disorders, and coagulopathies.
The most complex and potentially curative form of BMT where stem cells come from a matched donor. Used for leukemia, aplastic anemia, and inherited blood disorders.
Patient's own stem cells are harvested and reinfused after high-dose chemotherapy. Used for multiple myeloma and relapsed lymphomas.
Revolutionary immunotherapy where the patient's own T-cells are genetically reprogrammed to attack cancer cells.
The only curative treatment for beta-thalassemia major and sickle cell disease through allogeneic stem cell transplantation.
Personalised chemotherapy and next-generation targeted agents for lymphoma, leukaemia, and related disorders.
Send your medical reports and get a personalised treatment plan. The team reviews cases from 50+ countries and responds within 24 hours.
Our team responds within 24 hours
Share your reports and receive a personalised treatment recommendation within 48 hours — at no cost.